T32 DA07209/DA/NIDA NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1984	3
1986	2
1988	1
1989	3
1991	1
1992	3
1993	3
1994	3
1995	1
1996	2
1997	3
1998	3
1999	3
2000	3
2001	7
2002	5
2003	5
2004	4
2005	2
2006	4
2007	4
2008	3
2009	6
2010	3
2011	6
2012	6
2013	8
2014	10
2015	11
2017	1
2018	1
2020	1
2021	1
2022	0

1

Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.

Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO. Vandrey R, et al. Int Rev Psychiatry. 2014 Apr;26(2):237-47. doi: 10.3109/09540261.2014.901300. Int Rev Psychiatry. 2014. PMID: 24892898 Free PMC article. Review.

2

Nicotine reinforcement in never-smokers.

Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Duke AN, et al. Psychopharmacology (Berl). 2015 Dec;232(23):4243-52. doi: 10.1007/s00213-015-4053-4. Epub 2015 Sep 8. Psychopharmacology (Berl). 2015. PMID: 26345343 Free PMC article.

3

The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic.

Walsh SL, Eissenberg T. Walsh SL, et al. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S13-27. doi: 10.1016/s0376-8716(03)00056-5. Drug Alcohol Depend. 2003. PMID: 12738347 Review.

4

Behavioral economics and safe sex: Examining condom use decisions from a reinforcer pathology framework.

Harsin JD, Gelino BW, Strickland JC, Johnson MW, Berry MS, Reed DD. Harsin JD, et al. J Exp Anal Behav. 2021 Sep;116(2):149-165. doi: 10.1002/jeab.706. Epub 2021 Jul 5. J Exp Anal Behav. 2021. PMID: 34227121

5

Human drug discrimination and multiple chemical sensitivity: caffeine exposure as an experimental model.

Eissenberg T, Griffiths RR. Eissenberg T, et al. Environ Health Perspect. 1997 Mar;105 Suppl 2(Suppl 2):509-13. doi: 10.1289/ehp.97105s2509. Environ Health Perspect. 1997. PMID: 9167988 Free PMC article. Review.

6

Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users.

Herrmann ES, Weerts EM, Vandrey R. Herrmann ES, et al. Exp Clin Psychopharmacol. 2015 Dec;23(6):415-21. doi: 10.1037/pha0000053. Epub 2015 Oct 12. Exp Clin Psychopharmacol. 2015. PMID: 26461168 Free PMC article.

7

Changing profile of abused substances by older persons entering treatment.

Lofwall MR, Schuster A, Strain EC. Lofwall MR, et al. J Nerv Ment Dis. 2008 Dec;196(12):898-905. doi: 10.1097/NMD.0b013e31818ec7ee. J Nerv Ment Dis. 2008. PMID: 19077857 Free PMC article.

8

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.

Carbonaro TM, Johnson MW, Griffiths RR. Carbonaro TM, et al. Psychopharmacology (Berl). 2020 Aug;237(8):2293-2304. doi: 10.1007/s00213-020-05533-9. Epub 2020 Jun 5. Psychopharmacology (Berl). 2020. PMID: 32500212

9

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.

Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. Carbonaro TM, et al. Psychopharmacology (Berl). 2018 Feb;235(2):521-534. doi: 10.1007/s00213-017-4769-4. Epub 2017 Nov 7. Psychopharmacology (Berl). 2018. PMID: 29116367 Free PMC article.

10

Demand curves for hypothetical cocaine in cocaine-dependent individuals.

Bruner NR, Johnson MW. Bruner NR, et al. Psychopharmacology (Berl). 2014 Mar;231(5):889-97. doi: 10.1007/s00213-013-3312-5. Epub 2013 Nov 12. Psychopharmacology (Berl). 2014. PMID: 24217899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results